Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

6 references·16 citing·24 second hop

FromToDepth

this work references cited by second hop

References

1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
19873,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.458 cited
1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited
1988MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons312 cited
1988(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates300 cited

Cited by

2009Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview291 cited
2000Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users279 cited
20063,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings266 cited
2005Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy238 cited
2001Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems210 cited
2016Clinical applications of hallucinogens: A review.201 cited
2003Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

199 cited

20023,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics191 cited

2003Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users190 cited

2003Altered states: the clinical effects of Ecstasy190 cited

2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies188 cited

2013Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research185 cited

2002Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users181 cited

2006The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview179 cited

2003Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users171 cited

2001Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug170 cited